Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.

Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD.

Expert Rev Vaccines. 2012 Feb;11(2):211-20. doi: 10.1586/erv.11.184. Review.

PMID:
22309669
2.

Economic evaluations of rotavirus immunization for developing countries: a review of the literature.

Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ.

Expert Rev Vaccines. 2011 Jul;10(7):1037-51. doi: 10.1586/erv.11.65. Review.

PMID:
21806398
3.

Effects of vaccine on rotavirus disease in the pediatric population.

Dennehy PH.

Curr Opin Pediatr. 2012 Feb;24(1):76-84. doi: 10.1097/MOP.0b013e32834ee594. Review.

PMID:
22189398
4.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799
5.

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.

Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096.

PMID:
22520139
6.

Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.

Ustrup M, Madsen LB, Bygbjerg IC, Konradsen F.

Dan Med Bull. 2011 Oct;58(10):A4323. Review.

PMID:
21975154
7.

Rotavirus vaccines: update on global impact and future priorities.

Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.

Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Epub 2011 Dec 1. Review.

8.

Rotavirus vaccination.

Bjur KA, Jacobson RM.

Minerva Pediatr. 2009 Oct;61(5):515-21.

PMID:
19794377
9.

Issues with reducing the rotavirus-associated mortality by vaccination in developing countries.

Naghipour M, Nakagomi T, Nakagomi O.

Vaccine. 2008 Jun 19;26(26):3236-41. doi: 10.1016/j.vaccine.2008.04.004. Epub 2008 Apr 24.

PMID:
18472196
10.

Global impact of rotavirus vaccines.

Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, de Oliveira LH, Glass RI, Parashar UD.

Expert Rev Vaccines. 2010 Apr;9(4):395-407. doi: 10.1586/erv.10.17. Review. Erratum in: Expert Rev Vaccines. 2010 Jul;9(7):804.

PMID:
20370550
11.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

12.

Baseline estimates of diarrhea-associated mortality among United States children before rotavirus vaccine introduction.

Esposito DH, Holman RC, Haberling DL, Tate JE, Podewils LJ, Glass RI, Parashar U.

Pediatr Infect Dis J. 2011 Nov;30(11):942-7. doi: 10.1097/INF.0b013e3182254d19.

PMID:
21691244
13.

Rotavirus vaccines: development, current issues and future prospects.

Cunliffe NA, Bresee JS, Hart CA.

J Infect. 2002 Jul;45(1):1-9. Review.

PMID:
12217724
14.

Rotavirus vaccination within the South African Expanded Programme on Immunisation.

Seheri LM, Page NA, Mawela MP, Mphahlele MJ, Steele AD.

Vaccine. 2012 Sep 7;30 Suppl 3:C14-20. doi: 10.1016/j.vaccine.2012.04.018. Review.

PMID:
22939015
15.

Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1611-4.

16.

Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.

Amador JJ, Vasquez J, Orozco M, Pedreira C, Malespin O, De Oliveira LH, Tate J, Parashar U, Patel M.

Int J Infect Dis. 2010 Jul;14(7):e592-5. doi: 10.1016/j.ijid.2009.08.014. Epub 2009 Dec 22.

17.

Rotavirus vaccines: entering a new stage of deployment.

Nakagomi O, Cunliffe NA.

Curr Opin Infect Dis. 2007 Oct;20(5):501-7. Review.

PMID:
17762784
18.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
19.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
20.

Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?

Mirzayeva R, Steele AD, Parashar UD, Zaman K, Neuzil KM, Nelson EA.

Vaccine. 2009 Nov 20;27 Suppl 5:F120-9. doi: 10.1016/j.vaccine.2009.09.039. Review.

PMID:
19931711

Supplemental Content

Support Center